D-1613-2020 Class II Terminated

Recalled by RLC Labs Inc. — Phoenix, AZ

Recall Details

Product Type
Drugs
Report Date
September 23, 2020
Initiation Date
August 25, 2020
Termination Date
November 8, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

WP Thyroid, Westhroid Pure, 2 Grain (130 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5950-2 ; b) 30 Tablets, NDC 64727-5950-4; c) 60 Tablets, NDC 64727-5950-5; d) 90 Tablets, NDC 64727-5950-6; e) 100 Tablets, NDC 64727-5950-1; Rx Only, Manufactured by: RLC Labs Phoenix, AZ 85034

Reason for Recall

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Distribution Pattern

Nationwide in the United States

Code Information

All lots with expiry between 10/2020-07/2023